Psoriasis Trial, Recruiting NCT07471048 Sponsor: Sirt3 LLC Condition: Psoriasis
Back to Psoriasis

Psoriasis Trial, Recruiting

NCT07471048
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older at the time of signing up for the study.
  • A dermatologist (skin doctor) has confirmed you have stable psoriasis that you have had for at least 6 months.
  • You have other health conditions related to your psoriasis, such as psoriatic arthritis, as long as those conditions are not severe enough to need the types of treatments listed in the exclusion section below.
  • You are able to read and understand English.
  • You are able to read, understand, and sign a consent form agreeing to take part in the study.
  • You own a personal smartphone and are able to download an app called "Chloe by People Science."
  • You have a address within the United States where study products can be shipped to you.
  • You are willing and able to follow the study steps, such as collecting and mailing in blood samples.

Who may not be able to join:

  • You do not own a personal smartphone, do not have internet access, or are not willing to download the Chloe app.
  • You have taken certain non-biologic medicines that suppress the immune system (such as methotrexate, cyclosporine, or azathioprine) in the last 8 weeks.
  • You have taken certain biologic medicines (such as guselkumab, adalimumab, or etanercept — a type of injection or infusion therapy for conditions like psoriasis or arthritis) in the last 6 months.
  • You have taken any other experimental medicines as part of another study in the last 6 months.
  • You are currently pregnant, planning to become pregnant in the next 3 months, or are breastfeeding.
  • You have any other health conditions that might affect your digestive symptoms or make the study results harder to measure (confirm with trial site).
  • You have a significant illness or condition that the lead study doctor believes could affect your ability to take part or could affect the study results.
  • You have a known allergy or sensitivity to magnolia, rice, or hypromellose (a common coating used in capsules).
  • The lead study doctor believes, for any reason, that you are not suited to take part in this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 2013596845

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sirt3 LLC
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 September 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Relative change in plasma Beta defensin 2 from baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov